Despite the growing awareness about the importance of embracing Big Data, the bio-pharmaceutical sector has been slower than other industries to utilize Big Data due to the inherent costs and challenges that come with utilization. On the medical side, organizations have begun looking to Big Data as a way to improve everything from clinical trials to adherence. Recognizing the huge potential that Big Data holds for key medical decisions, organizations are taking steps to develop greater Big Data capabilities.
Best Practices, LLC undertook this study to probe current & future trends and best practices for Big Data utilization across Medical Affairs functions. The study will help leaders to better understand the growing influence of Big Data in the bio-pharmaceutical sector and how it impacts medical, HEOR, and commercial operations in the U.S.
Download Full Report: http://bit.ly/2bQv4AV